Four Drugmakers Must Face Lawsuit Over Drug Overcharges
A U.S. appeals court revived a lawsuit accusing four major drugmakers of overcharging for medications. The case claims the firms defrauded the U.S. government.
Xurve View
Insights:
Xurve View
A federal appeals court in the United States has reinstated a whistleblower lawsuit against four major pharmaceutical companies. The legal action accuses AbbVie Inc., AstraZeneca PLC, NOVARTIS AG-2ND LINE, and Sanofi of defrauding government programs by overcharging for medications intended for low-income and uninsured patients.
